摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl 8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate

中文名称
——
中文别名
——
英文名称
tert-butyl 8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate
英文别名
tert-butyl (1R,5S)-8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate
tert-butyl 8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate化学式
CAS
——
化学式
C12H19NO2
mdl
——
分子量
209.288
InChiKey
ZJQQGLKPJWUKNL-VHSXEESVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl 8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate4-二甲氨基吡啶氢气硼酸碳酸氢钠三乙胺三氟乙酸 作用下, 以 甲醇二氯甲烷乙酸乙酯 为溶剂, 10.0~20.0 ℃ 、101.33 kPa 条件下, 反应 65.0h, 生成 古卡因
    参考文献:
    名称:
    (-)-可卡因和(-)-铁精氨酸的全合成
    摘要:
    从已知的Betti基础衍生物(+)-(7a R,10 R,12 S)-10-(1 H-苯并三唑-1-基)-7a,8,9,10-四氢-12-苯基-12 H-萘[1,2- e ]吡咯并[2,1- b ] [1,3]恶嗪。在该新颖途径中,RCM反应和1,3-偶极环加成被用作对映烷骨架的对映选择性构建和3-溴-2-异恶唑啉环的区域选择性引入作为掩蔽的顺式-2,3-二取代基的关键步骤。获得所需的前体(2 S,5R)-2-烯丙基-5-乙烯基吡咯烷用于RCM反应,我们开发了一种通用且实用的方法,用于制备带有烯键和/或炔烃取代基的对映体纯的顺式-2,5-二取代的吡咯烷。我们还提供了两种高效的途径,可将3-溴-2-异恶唑啉环转化为(-)-可卡因和(-)-铁精氨酸中所需的顺式-2,3-二取代基。
    DOI:
    10.1021/jo200069m
  • 作为产物:
    描述:
    盐酸古柯碱 在 palladium on activated charcoal 盐酸1-氧化-2-巯基吡啶sodium periodate草酰氯1-氯乙基氯甲酸酯氢气三乙胺N,N-二甲基甲酰胺 作用下, 以 甲醇 为溶剂, 75.0 ℃ 、413.69 kPa 条件下, 反应 94.0h, 生成 tert-butyl 8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate
    参考文献:
    名称:
    Enantiospecific Synthesis of Natural (−)-Cocaine and Unnatural (+)-Cocaine from d- and l-Glutamic Acid
    摘要:
    Natural (-)-cocaine and unnatural (+)-cocaine have been synthesized enantiospecifically from D- and L-glutamic acid, respectively. The axial-equatorial substitutents were introduced by a stereo- and regiospecific dipolar cycloaddition to the corresponding (LR,5S)- and (1S,5R)-N-BOC-nortropenes with (ethoxycarbonyl)formonitrile N-oxide. A sequence of subsequent stereochemically controlled transformations converted the fused isoxazoline to the requisite P-hydroxy ester. Synthesis of the key intermediate N-BOC-nortropenes involved construction of the 8-azabicyclo[3.2.1]octane framework by Dieckmann condensation of cis-5-substituted D-and L-proline esters. For comparison, (1R,SS)-N-BOC-nortropene also was derived by degradation from natural cocaine. The cis-5-substituted D-and L-proline esters were obtained by sulfide contraction and subsequent catalytic hydrogenation to induce stereospecifically the C-5 stereochemistry from D-and L-thiopyroglutamate, which in turn were prepared from D-and L-glutamic acids, respectively.
    DOI:
    10.1021/jo980153t
点击查看最新优质反应信息

文献信息

  • Novel tricyclic Δ2-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: Synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes
    作者:Clelia Dallanoce、Fabio Frigerio、Giuliana Martelli、Giovanni Grazioso、Carlo Matera、Diego Yuri Pomè、Luca Pucci、Francesco Clementi、Cecilia Gotti、Marco De Amici
    DOI:10.1016/j.bmc.2010.04.065
    日期:2010.6.15
    assayed at α4β2 and α7 neuronal acetylcholine receptors (nAChRs). The results of competition binding experiments indicated for the new derivatives a reduction of the affinity at the α4β2 subtype in comparison with the reference molecules, coupled with an overall negligible affinity at the α7 subtype. The binding mode of the bromo-Δ2-isoxazolines 4b and 7b, which were the highest affinity ligands in the series
    A组新的三环Δ的2个-isoxazolines(图4b,图5b,图7a - b,和图8a - b)和3-氧代-异恶唑烷(6A - b和图9a - b通过与1,3,3-偶极环加成反应制备涉及结构上的胱氨酸或去铁血红素的α-己内酯和氧化溴腈。在α4β2和α7神经元乙酰胆碱受体(nAChRs)处测定了目标化合物。竞争结合实验的结果表明,与参考分子相比,新衍生物对α4β2亚型的亲和力降低,并且对α7亚型的总体亲和力可忽略不计。溴- Δ的结合模式2 -isoxazolines 4B和图7b,这是在该系列中的最高亲和配体(ķ我 = 0.92和0.75μM,分别地),通过应用α4β2nAChRs的的最近开发的模型进行分析。
  • Enantiospecific Synthesis of Natural (−)-Cocaine and Unnatural (+)-Cocaine from <scp>d</scp>- and <scp>l</scp>-Glutamic Acid
    作者:Ronghui Lin、Josep Castells、Henry Rapoport
    DOI:10.1021/jo980153t
    日期:1998.6.1
    Natural (-)-cocaine and unnatural (+)-cocaine have been synthesized enantiospecifically from D- and L-glutamic acid, respectively. The axial-equatorial substitutents were introduced by a stereo- and regiospecific dipolar cycloaddition to the corresponding (LR,5S)- and (1S,5R)-N-BOC-nortropenes with (ethoxycarbonyl)formonitrile N-oxide. A sequence of subsequent stereochemically controlled transformations converted the fused isoxazoline to the requisite P-hydroxy ester. Synthesis of the key intermediate N-BOC-nortropenes involved construction of the 8-azabicyclo[3.2.1]octane framework by Dieckmann condensation of cis-5-substituted D-and L-proline esters. For comparison, (1R,SS)-N-BOC-nortropene also was derived by degradation from natural cocaine. The cis-5-substituted D-and L-proline esters were obtained by sulfide contraction and subsequent catalytic hydrogenation to induce stereospecifically the C-5 stereochemistry from D-and L-thiopyroglutamate, which in turn were prepared from D-and L-glutamic acids, respectively.
  • Total Synthesis of (−)-Cocaine and (−)-Ferruginine
    作者:Guolin Cheng、Xinyan Wang、Rui Zhu、Changwei Shao、Jimin Xu、Yuefei Hu
    DOI:10.1021/jo200069m
    日期:2011.4.15
    synthesis of tropane alkaloids ()-cocaine and ()-ferruginine were accomplished in nine steps each and in 55% and 46% overall yields, respectively, starting from the known Betti base derivative (+)-(7aR,10R,12S)-10-(1H-benzotriazol-1-yl)-7a,8,9,10-tetrahydro-12-phenyl-12H-naphtho[1,2-e]pyrrolo[2,1-b][1,3]oxazine. In this novel route, RCM reaction and 1,3-dipolar cycloaddition were employed as key steps
    从已知的Betti基础衍生物(+)-(7a R,10 R,12 S)-10-(1 H-苯并三唑-1-基)-7a,8,9,10-四氢-12-苯基-12 H-萘[1,2- e ]吡咯并[2,1- b ] [1,3]恶嗪。在该新颖途径中,RCM反应和1,3-偶极环加成被用作对映烷骨架的对映选择性构建和3-溴-2-异恶唑啉环的区域选择性引入作为掩蔽的顺式-2,3-二取代基的关键步骤。获得所需的前体(2 S,5R)-2-烯丙基-5-乙烯基吡咯烷用于RCM反应,我们开发了一种通用且实用的方法,用于制备带有烯键和/或炔烃取代基的对映体纯的顺式-2,5-二取代的吡咯烷。我们还提供了两种高效的途径,可将3-溴-2-异恶唑啉环转化为(-)-可卡因和(-)-铁精氨酸中所需的顺式-2,3-二取代基。
查看更多

同类化合物

(2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁 阿维巴坦中间体1 阿曲生坦中间体 阿曲生坦 间甲氧基苯乙腈 铂(2+)羟基乙酸酯-吡咯烷-3-胺(1:1:1) 钾2-氧代吡咯烷-1-磺酸酯 钠1-[(9E)-9-十八碳烯酰基氧基]-2,5-二氧代-3-吡咯烷磺酸酯 金刚烷-1-基(吡咯烷-1-基)甲酮 酸-1-吡咯烷-1,4-氨基-2-甲基-1,1,1-二甲基乙基酯,(2S,4R)- 酚丙氢吡咯 试剂3-Mercaptopropanyl-N-hydroxysuccinimideester 西他利酮 血红素酸 螺虫乙酯残留代谢物Mono-Hydroxy 萘吡坦